Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01390272 · ClinicalTrials.gov registry record · NA

Titrated Disease Management for Patients With Hypertension

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
385
Enrollment target

NCT01390272: Completed NA study, sponsored by VA Office of Research and Development.

NCT01390272 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 385 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01390272, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
385 participants
Enrollment target

Study Summary

This randomized clinical trial examines whether programs aimed at matching resources to patient hypertension (i.e. high blood pressure) control lead to greater reduction in systolic blood pressure (top number of blood pressure reading) than simply having maintenance phone calls in addition to usual care. Answering this question will provide important evidence concerning the overall goal of sustained long-term implementation of the disease management programs as part of patient aligned care teams in the Veterans Affairs and other healthcare systems.

Interventions

  • BEHAVIORAL Booster/ low resource
  • BEHAVIORAL Medium/Level 1 resource intensity
  • BEHAVIORAL High/Level 2 resource intensity

Trial Details

FieldValue
Enrollment Target 385 participants
Start Date 2012-07-27
Est. Completion 2016-10-31
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT01390272

The ClinicalTrials.gov registry entry for NCT01390272 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 385 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Booster/ low resource is the first listed.

NCT01390272 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01390272 about?

NCT01390272 is a clinical study titled "Titrated Disease Management for Patients With Hypertension". This randomized clinical trial examines whether programs aimed at matching resources to patient hypertension (i.e. high blood pressure) control lead to greater reduction in systolic blood pressure (top number of blood pressure reading) than simply having maintenance phone calls in addition to usual ...

What is the current status of trial NCT01390272?

This trial is currently completed. It is a NA study. The enrollment target is 385 participants. The study started on 2012-07-27. Estimated completion is 2016-10-31.

What interventions are being tested in trial NCT01390272?

The interventions under investigation include: Booster/ low resource (BEHAVIORAL), Medium/Level 1 resource intensity (BEHAVIORAL), High/Level 2 resource intensity (BEHAVIORAL).

Who is sponsoring clinical trial NCT01390272?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.